These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 16882345)

  • 1. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer.
    Yang J; Ramnath N; Moysich KB; Asch HL; Swede H; Alrawi SJ; Huberman J; Geradts J; Brooks JS; Tan D
    BMC Cancer; 2006 Aug; 6():203. PubMed ID: 16882345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic evaluation of CapG, gelsolin, P-gp, GSTP1, and Topo-II proteins in non-small cell lung cancer.
    Zhu WY; Hunag YY; Liu XG; He JY; Chen DD; Zeng F; Zhou JH; Zhang YK
    Anat Rec (Hoboken); 2012 Feb; 295(2):208-14. PubMed ID: 22190510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.
    Ramnath N; Hernandez FJ; Tan DF; Huberman JA; Natarajan N; Beck AF; Hyland A; Todorov IT; Brooks JS; Bepler G
    J Clin Oncol; 2001 Nov; 19(22):4259-66. PubMed ID: 11709570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications.
    Hashimoto K; Araki K; Osaki M; Nakamura H; Tomita K; Shimizu E; Ito H
    Pathobiology; 2004; 71(4):193-200. PubMed ID: 15263808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication.
    Fujioka S; Shomori K; Nishihara K; Yamaga K; Nosaka K; Araki K; Haruki T; Taniguchi Y; Nakamura H; Ito H
    Lung Cancer; 2009 Aug; 65(2):223-9. PubMed ID: 19144445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between expression of metallothionein and expression of Ki-67 and MCM-2 proliferation markers in non-small cell lung cancer.
    Werynska B; Pula B; Muszczynska-Bernhard B; Piotrowska A; Jethon A; Podhorska-Okolow M; Dziegiel P; Jankowska R
    Anticancer Res; 2011 Sep; 31(9):2833-9. PubMed ID: 21868526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of gelsolin expression level and variability in non-small cell lung cancer.
    Yang J; Tan D; Asch HL; Swede H; Bepler G; Geradts J; Moysich KB
    Lung Cancer; 2004 Oct; 46(1):29-42. PubMed ID: 15364130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.
    Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY
    Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
    Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
    J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma.
    Vigouroux C; Casse JM; Battaglia-Hsu SF; Brochin L; Luc A; Paris C; Lacomme S; Gueant JL; Vignaud JM; Gauchotte G
    Lung Cancer; 2015 Aug; 89(2):189-96. PubMed ID: 26013954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance.
    Tokuyasu N; Shomori K; Nishihara K; Kawaguchi H; Fujioka S; Yamaga K; Ikeguchi M; Ito H
    Gastric Cancer; 2008; 11(1):37-46. PubMed ID: 18373176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.
    May M; Burger M; Otto W; Hakenberg OW; Wieland WF; May D; Hofstädter F; Götz S; Niessl N; Fritsche HM; Birnkammer K; Gilfrich C; Peter J; Jain A; Koch S; Lebentrau S; Riedmiller H; Rössler W; Denzinger S; Brookman-May S; Gunia S
    BJU Int; 2013 Aug; 112(4):E383-90. PubMed ID: 23305250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis.
    Obermann EC; Went P; Zimpfer A; Tzankov A; Wild PJ; Stoehr R; Pileri SA; Dirnhofer S
    BMC Cancer; 2005 Dec; 5():162. PubMed ID: 16368013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC).
    Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR
    Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer.
    Liu M; Li JS; Tian DP; Huang B; Rosqvist S; Su M
    Histol Histopathol; 2013 Apr; 28(4):481-92. PubMed ID: 23329420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Takeda K; Aburatani H; Oizumi S; Konishi J; Kaga K; Matsuno Y; Birrer MJ; Nishimura M; Dosaka-Akita H
    Lung Cancer; 2011 May; 72(2):229-37. PubMed ID: 20884074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma.
    Kato H; Miyazaki T; Fukai Y; Nakajima M; Sohda M; Takita J; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Asao T; Kuwano H
    J Surg Oncol; 2003 Sep; 84(1):24-30. PubMed ID: 12949987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade.
    Burger M; Denzinger S; Hartmann A; Wieland WF; Stoehr R; Obermann EC
    Br J Cancer; 2007 Jun; 96(11):1711-5. PubMed ID: 17505513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
    Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH
    Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.